Ernexa Therapeutics Inc. Long-Lived Assets
Ernexa Therapeutics Inc. (ERNA) had Long-Lived Assets of $3.31 million as of 2013-06-30, per its 10-Q filed 2013-08-14.
Discontinued › Notes
us-gaap:NoncurrentAssets · last filed 2013-08-14
- 2013-06-30: Long-Lived Assets $3.31M.
- 2013-03-31: Long-Lived Assets $3.53M.
- 2012-12-31: Long-Lived Assets $3.78M.
- 2012-09-30: Long-Lived Assets $3.92M.
| Period end | Long-Lived Assets |
|---|---|
| 2013-06-30 | $3.31M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $3.53M 10-Q · filed 2013-05-13 |
| 2012-12-31 | $3.78M 10-Q · filed 2013-08-14 |
| 2012-09-30 | $3.92M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $4.22M 10-Q · filed 2012-08-14 |
| 2011-12-31 | $4.25M 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |